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Background In hemorrhagic shock (HS), volume
replacement with crystalloid solution can restore the
hemodynamic status and decrease mortality. However, it
can also lead to tissue edema and pulmonary
congestion, as well as increasing vascular permeability.
Here, we analyzed the effects that resuscitation with
lactated Ringer’s solution (LRS) or administration of the
vasopressin analog terlipressin has on renal function in a
porcine model of HS.
Methods Using pressure-controlled bleeding, we
induced pigs to HS, maintaining mean arterial pressure
(MAP) at 40 mm Hg for 30 min. Animals were divided
into 4 groups: sham (anesthesia only); shock-only (HS
induction); shock+LRS (HS induction and subsequent
resuscitation with LRS at 3 times the volume of blood
removed); and shock+Terli (HS induction and subsequent
bolus administration of 2 mg of terlipressin). Parameters
were evaluated at baseline, then at 30, 60, and 120 min
after treatment (T30, T60, and T120, respectively).
Animals were euthanized at T60 or T120.
Results Both treatments restored MAP to baseline
values. At T30 and T60, creatinine clearance was highest
in shock+LRS pigs, whereas it was highest in shock
+Terli pigs at T120. Both treatments initially induced
hyponatremia, although urinary excretion of all ions was
higher in shock+LRS pigs at T30. Both treatments
restored Na–K–2Cl cotransporter expression, whereas
only terlipressin restored aquaporin 2 expression. Both
treatments also prevented HS-induced acute tubular
necrosis. Expression of the vasopressin receptors V1a
and V2 was highest in shock-only pigs. At T120, V1a
expression was lowest in shock+LRS pigs.
Discussion Terlipressin might be useful for preventing
HS-induced acute kidney injury.
INTRODUCTION
Hemorrhagic shock (HS), a condition resulting
from rapid, signiﬁcant loss of intravascular volume,
can lead to hemodynamic instability, followed by
decreased oxygen delivery, inadequate tissue perfu-
sion, cell hypoxia, increased vascular permeability,
and organ damage.1 In cases of trauma, HS is the
leading cause of morbidity and mortality.2 Every
year, trauma kills 5.8 million people, making it the
third leading cause of death and disability, after car-
diovascular disease and cancer.2 In the city of São
Paulo, Brazil, the incidence of death resulting from
trafﬁc accidents is 9.6/100 000 population, com-
pared with 3.3/100 000 population in New York
City.3–5 The ﬁrst organs to become ischemic after
hemorrhage or trauma are the kidneys and the
brain.6 Acute kidney injury (AKI), which is asso-
ciated with high mortality, involves a rapid decrease
in the glomerular ﬁltration rate, often caused by
vasoconstriction or a loss of autoregulation.7 In add-
ition, ischemia and reperfusion activate mechanisms
of cell death,8 including apoptosis, autophagy-asso-
ciated cell death (cytoplasmic vacuolization, loss of
organelles, and accumulation of vacuoles with mem-
brane whorls), and necrosis (progressive swelling of
cells and organelles; plasma membrane rupture; and
leakage of proteases and lysosomes into the extracel-
lular compartment). Furthermore, ischemia/reperfu-
sion injury is associated with a decrease in renal
expression of the Na–K–2Cl cotransporter
(NKCC2)—the major transporter for apical sodium
reabsorption by the thick ascending limb—and of
aquaporin 2 (AQP2)—the vasopressin-regulated
water channel—which could contribute to increas-
ing urinary excretion of sodium, chloride, and
water.9 10 The vasopressin receptors V1a and V2
also play a role in HS. The V1a receptor, which is
found in the vascular smooth muscle, is responsible
for the vasoconstriction induced by administration
of vasopressin, whereas the V2 receptor, which is
predominantly found in the distal tubule and col-
lecting ducts of the kidney, mobilizes AQP2 to the
apical membrane.11–13
The standard resuscitation protocol for HS
mandates the use of large volumes of crystalloids.
However, that practice can have adverse
effects, such as interstitial edema in the gut, lungs,
and kidneys;14–17 increased production of
pro-inﬂammatory cytokines;18 and increased intracra-
nial pressure.19 The vasopressin analog terlipressin has
been shown to be effective as a vasoconstrictor agent
in the management of catecholamine-resistant arterial
hypotension in septic shock and of acute gastrointes-
tinal bleeding in patients with hepatorenal syn-
drome.20 21 In a recent study employing a porcine
model of HS, we showed that early treatment with ter-
lipressin was effective in restoring cerebral perfusion
pressure, as well as in preventing HS-induced changes
in the brain expression of markers of water balance,
oxidative stress, and apoptosis.22 However, in that
same study, animals receiving lactated Ringer’s solu-
tion (LRS) showed a greater increase in intracranial
pressure than did those receiving terlipressin, a differ-
ence that could be attributed to an increase in brain
water content in the former group. Nevertheless, we
found that terlipressin maintained cerebral perfusion
pressure while keeping intracranial pressure at levels
similar to those observed for a control group.22 In the
present study, which was conducted in parallel with
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that study, we used the same porcine model in order to test our
hypothesis that the effectiveness of terlipressin in treating




All experimental procedures were approved by the Medical Ethics
Committee of the University of São Paulo University Hospital
(Protocol no. 067/11) and by the Medical and Research Ethics
Committee of the University of São Paulo School of Medicine
Hospital das Clínicas (Protocol no. 280/13). The animals (Large
White pigs, all female) were obtained from a local farm that specia-
lizes in providing animals for use in research and certiﬁes that the
animals it provides are free of disease. This study was conducted in
parallel with another study employing the same animals and proce-
dures.22 However, that study evaluated the effects that HS and the
two different treatments had on cerebral perfusion pressure and
brain tissue markers of water balance, oxidative stress, and
apoptosis.
Preparatory procedures
Female large White pigs (n=47), weighing 20–30 kg, were fasted
(with free access to water) for 12 hours before the experiments.
The animals were premedicated with intramuscular injections of
ketamine (5 mg/kg) and midazolam (0.25 mg/kg), after which
anesthesia was induced with intravenous propofol (7 mg/kg). After
endotracheal intubation, anesthesia was maintained with isoﬂurane
vaporized into a mixture of 40% oxygen and 60% nitrogen. Each
animal was then connected to a ventilator (Fabius GS Premium;
Dräger, Lübeck, Germany) on which the tidal volume was set at
8 mL/kg, with a positive end-expiratory pressure of 5 cm H2O.
The respiratory rate was adjusted to maintain normocapnia (arter-
ial carbon dioxide tension, 35–45 mmHg). Throughout the
experiments, the animals received continuous infusion of LRS
(4 mL/kg/hours of ventilation) and pancuronium (0.3 mg/kg/hours
of ventilation). Body temperature was maintained at 38°C using a
heated mat (Medi-Therm II; Gaymar Industries, Orchard Park,
New York, USA). The two femoral arteries were catheterized for
measurement of mean arterial pressure (MAP) and withdrawal of
blood to induce HS, respectively. Another catheter was inserted
into the right femoral vein for later administration of treatments.
At each time point evaluated, arterial and mixed venous blood
were sampled for analysis—which included measurement of
serum levels of hemoglobin, sodium, and potassium—in a blood
gas analyzer (ABL 555; Radiometer, Copenhagen, Denmark).
Ancillary preparatory procedures
For the purposes of the parallel study,22 the same animalsi
employed in our study were submitted to a number of procedures
unrelated to the evaluation of renal function. A pulmonary artery
catheter was surgically introduced into the right internal jugular
vein and advanced to the wedge position. Two burr holes were
placed over the right and left coronal sutures, respectively. In the
right hemisphere, an intraparenchymal probe was inserted into the
cerebral cortex for measurement of brain tissue oxygen pressure.
In the left hemisphere, a ﬁberoptic probe was inserted into the epi-
dural space for continuous monitoring of intracranial pressure.
Experimental design
Following surgical preparation, animals were allowed to stabilize
for 30 min before being randomly divided into four groups:
sham (n=6), consisting of animals that were anesthetized but
were not subjected to HS; shock-only (n=12), consisting of
animals subjected to HS and left untreated; shock+LRS (n=15),
consisting of animals subjected to HS and subsequently treated
with LRS (at a volume equal to three times that of the blood
removed); and shock+Terli (n=14), consisting of animals sub-
jected to HS and subsequently treated with a 2 mg bolus of terli-
pressin (Glypressin; Ferring Pharmaceuticals, Copenhagen,
Denmark). Randomization was performed, prior to baseline
measurements, as previously described.9
Using pressure-controlled bleeding, we induced pigs to HS,
maintaining the target MAP (40 mm Hg) for 30 min. For all
animals, data were collected at four time points: baseline (prior
to blood removal); shock30 (30 min after achieving the target
MAP, immediately prior to treatment); T30 (30 min after treat-
ment); and T60 (60 min after treatment). For some of the
animals in each group (sham, n=2; shock-only, n=3; shock
+LRS, n=9; and shock+Terli, n=8), the study was continued
for an additional 60 min, allowing data to be collected at a ﬁfth
time point (T120, 120 min after treatment). At the end of the
study period (T60 or T120), animals were euthanized with an
overdose of isoﬂurane. Kidney fragments were frozen in liquid
nitrogen and stored at −70°C or ﬁxed in 10% neutral-buffered
formalin solution for 24 hours and in 70% alcohol thereafter.
Analysis of blood and urine
Urine samples were centrifuged in aliquots to remove suspended
material, and the supernatants were analyzed. Serum and
urinary levels of phosphorus, chloride, and magnesium were
measured with ion-selective electrodes (NOVA Biomedical,
Waltham, Massachusetts, USA), whereas serum levels of creatin-
ine and urea were measured with kinetic techniques. We mea-
sured urine osmolality using a freezing-point osmometer (3D3;
Advanced Instruments, Norwood, Massachusetts, USA).
Creatinine clearance was calculated by the following formula:
Ccreat ¼ (Ucreat  Uvolume)=Pcreat
where Ccreat is the creatinine clearance, Ucreat the urinary con-
centration of creatinine (mg/dL), Uvolume the urine output in
microliters per 30 min, and Pcreat the plasma concentration of
creatinine (mg/dL).
Kidney fractions
Kidney samples were homogenized in ice-cold isolation solution
(200 mM mannitol, 80 mM HEPES, and 41 mM potassium
hydroxide, pH 7.5) containing a protease inhibitor cocktail
(Sigma Chemical, St Louis, Missouri, USA) in a homogenizer
(PT 10/35; Brinkmann Instruments, Westbury, New York, USA).
To remove nuclei and cell debris, homogenates were centrifuged
at 2000×g for 15 min at 4°C. Supernatants were isolated, and
protein was quantiﬁed by Bradford assay (BioAgency
Laboratórios, São Paulo, Brazil).
Electrophoresis and immunoblotting
Kidney samples were run on polyacrylamide minigels. After trans-
fer by electroelution to nitrocellulose membranes (GE Healthcare,
Little Chalfont, UK), blots were blocked with 5% non-fat dry milk
in Tris-buffered saline. Blots were then incubated overnight with
antibodies against AQP2 (1:1000) and NKCC2 (1:500), as well as
iAlthough the parallel study employed the same animals, in the same
groups, the designations used in order to identify the experimental
groups differed from those used in the present study: HAEMO versus
shock-only; LR versus shock+LRS; and TERLI versus shock+Terli.
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against V1a and V2 (1:1000 for both), all of which were obtained
from Santa Cruz Biotechnology (Dallas, Texas, USA). The labeling
was visualized with a horseradish peroxidase-conjugated second-
ary antibody (antigoat, 1:10 000; Sigma Chemical) and enhanced
chemiluminescence (ECL) detection (Amersham Pharmacia
Biotech, Piscataway, New Jersey, USA).
Proteins
We scanned the ECL ﬁlms with an imaging system (Alliance 4.2;
UVItec, Cambridge, UK). We then used densitometry to
perform a quantitative analysis of the antibodies, normalizing
the bands to actin expression.
Light microscopy
Four micrometer histological sections of kidney tissue were
stained with H&E and examined under light microscopy. In
40–60 grid ﬁelds (0.245 mm2 each; magniﬁcation, ×400), we
graded the proportional renal damage (tubular epithelial swel-
ling, vacuolar degeneration, necrosis, and desquamation) as
follows: 0, <5%; I, 5–25%; II, 26–50%; III, 51–75%; and IV,
>75%. To minimize bias in the morphometric analysis, the
observer was blinded to the treatment groups. The mean scores
were calculated by animal and by group.
Statistical analysis
We analyzed physiological parameters across groups and over
time with GraphPad Prism V.5.03 for Windows (GraphPad
Software, San Diego, California, USA), using one-way analysis
of variance followed by the Student-Newman-Keuls test. The
results are presented as mean±SE. For all analyses, values of
p<0.05 were considered statistically signiﬁcant.
RESULTS
Terlipressin and LRS reduce mortality in HS
The mean volume of blood withdrawn was similar among the
experimental groups, averaging 60% of the estimated total
blood volume (shock-only group, 1083±124 mL; shock+LRS
group, 1162±203 mL; and shock+Terli group, 1011±215 mL).
By T120, the number of deaths was signiﬁcantly higher in the
shock-only group than in the other groups (6 deaths at a mean
of 41±15 min after shock30, p=0.0007). In the shock+Terli
group, only one animal died (at 80 min after shock30).
Terlipressin and LRS partially restore blood pressure after HS
As can be seen in table 1, both treatments were able to partially
restore MAP at T30, T60, and T120.
Terlipressin protects glomerular ﬁltration in HS
As was expected, HS resulted in a decrease in glomerular ﬁltra-
tion, as estimated by measuring creatinine clearance (ﬁgure 1).
As was also expected, creatinine clearance was markedly lower
in the shock-only group at all of the time points evaluated. Only
three of the shock-only pigs were evaluated at T120, and all
three of those animals were anuric at that point. At T30 and
T60, creatinine clearance was lower in the shock+Terli group
than in the shock+LRS group, in which it was comparable to
that observed in the sham group (ﬁgure 1). However, by T120,
that situation had been inverted, creatinine clearance being
lower in the shock+LRS group than in the shock+Terli group
(ﬁgure 1). At T30 and T60, urine volume was signiﬁcantly
lower in the shock-only group than in the other groups. By
T120, the urine output of the animals in the shock-only group
had dropped to zero. At T30 and T60, the shock+LRS pigs pre-
sented higher urine volume than did the shock+Terli pigs.
However, there was thereafter an inversion similar to that
observed for creatinine clearance, urine volume at T120 being
higher in the shock+Terli group than in the shock+LRS group
(ﬁgure 1).
Terlipressin protects tubular function in HS
The shock-only pigs presented hyponatremia at T60 and hyper-
natremia at T120. Throughout the study period, serum sodium
levels were lower in the shock+LRS and shock+Terli groups
than in the sham group (table 2). It is of note that, at T120, the
hyponatremia was more pronounced in the shock+Terli group
than in the shock+LRS group. As expected, the shock-only
group presented higher serum levels of potassium at all of the
time points evaluated, an effect that was mitigated in the shock
+LRS and shock+Terli groups (table 2). At T60, the shock
+LRS and shock+Terli groups presented serum chloride levels
that were lower than those observed for the sham group. By
T30, the shock-only pigs had developed hyperphosphatemia,
although the condition did not persist to T60 or T120. In the
shock+LRS group, post-treatment serum phosphorus levels
were similar to those observed for the sham group. At T30 and
T60, serum levels of phosphorus were higher in the shock
+Terli group than in the shock+LRS group. The shock-only
pigs also presented hypermagnesemia throughout the study
period. At T30 and T60, serum levels of magnesium were lower
in the shock+LRS group than in the shock-only group, as well
as being higher in the shock+Terli group than in the shock
+LRS group.
Table 2 shows the urinary excretion of ions and urea, together
with urine osmolality. At shock30, urinary excretion of sodium
and potassium was lower in the shock-only, shock+LRS, and
shock+Terli groups than in the sham group. At all time points
evaluated, urinary excretion of sodium, potassium, chloride,
magnesium, phosphorus, and urea was lowest in the shock-only
group. At T30, urinary excretion of sodium, potassium, chlor-
ide, magnesium, phosphorus, and urea was markedly higher in
the shock+LRS group than in the other groups. However, at
T60, urinary excretion of all analyzed ions and of urea were
lower in the shock+LRS group than in the sham and shock
+Terli groups. In fact, at T120, the shock+LRS pigs continued
to show marginally decreased urinary excretion of sodium,
potassium, chloride, magnesium, urea, and phosphorus in com-
parison with the sham and shock+Terli pigs. In the shock+Terli
Table 1 Mean arterial pressure in the various groups at the
various time points evaluated
MAP (mm Hg)
Time point
Group Baseline Shock30 T30 T60 T120
Sham 70.5±2.4 77.0±3.7 75.5±3.1 72.5±2.3 71±1.0
Shock-only 72.9±2.8 40.0±1.1a 40.0±2.4a 49.0±4.0b 43.3±8.6c
Shock+LRS 73.6±1.2 42.8±1.3a 60.0±2.5b,d 58.0±2.6c 53.0±2.2
Shock+Terli 70.8±1.4 41.5±1.0a 64.2±2.2b,d 60.1±3.4c 56.9±3.7
Values are mean±SE.
ap<0.001 vs sham; bp<0.01 vs sham; cp<0.05 vs sham; dp<0.05 vs shock30.
MAP, mean arterial pressure; Sham, anesthetized but not subjected to hemorrhagic
shock; Shock+LRS, subjected to hemorrhagic shock and subsequently treated with
LRS at a volume equal to three times that of the blood removed; Shock+Terli,
subjected to hemorrhagic shock and subsequently treated with a 2 mg bolus of
terlipressin; Shock30, 30 min after achieving the target MAP (immediately prior to
treatment); Shock-only, subjected to hemorrhagic shock and left untreated; T120,
120 min after treatment; T30, 30 min after treatment; T60, 60 min after treatment.
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group, urinary excretion of sodium, potassium, chloride, and
urea remained constant at T30 and T60, although that of phos-
phorus was elevated at T120. At T30 and T60, urine osmolality
was lower in the shock+LRS and shock+Terli groups than in
the sham group.
At T60, renal expression of AQP2 was signiﬁcantly lower in
shock-only pigs than in sham pigs (52.5±3.2% vs 100±1.1%,
p<0.001), as well as being signiﬁcantly lower in shock+LRS
pigs than in sham and shock+Terli pigs (38.7±6.6% vs 100
±1.1% and 82.5±7.8%, p<0.001 for both; ﬁgure 2). At T120,
AQP2 expression was signiﬁcantly lower in the shock-only and
shock+LRS groups than in the sham and shock+Terli groups
(22.5±2.5% and 43.3±12% vs 96.7±3.3% and 107.5±4.8%,
p<0.001 for both; ﬁgure 2).
At T60, NKCC2 protein expression was signiﬁcantly lower in
the kidneys of shock-only pigs than in those of sham, shock
+LRS, and shock+Terli pigs (38.7±18.1% vs 99.3±0.7%, 100
±0.8%, and 90±6.1%, p<0.01 for all; ﬁgure 2), indicating that
terlipressin and LRS both restore that expression after HS. At
T120, NKCC2 expression was still lower in the shock-only
group than in the sham and shock+Terli groups (27.7±1.7% vs
101.7±1.7% and 92.5±12.5%, p<0.01 for both), as well as
being quite low in the shock+LRS group (50±20.8%, p<0.05
vs sham and shock+Terli; ﬁgure 2).
Terlipressin protects tubular damage in HS
Figure 3 shows that renal tubular damage (acute tubular necro-
sis) was more extensive in the shock-only group than in the
sham, shock+LRS, and shock+Terli groups (0.45±0.1 vs 0.05
±0.00, 0.16±0.24, and 0.10±0.02, p<0.01 for all).
Expression of V1a and V2
At T60, protein expression of V1a was higher in the shock-only
group than in the sham, shock+LRS, and shock+Terli groups
(130±6.8% vs 93.3±4.4%, 80.0±4.6%, and 107.5±4.8%,
p<0.01 for all), as well as being higher in the shock+Terli
group than in the shock+LRS group (p<0.01; ﬁgure 4). At
T120, V1a expression was still higher in the shock-only group
than in the sham and shock+LRS groups (112.3±1.4% vs 100
±0.6% and 74±6.7%, p<0.05 for both), although it was also
quite high in the shock+Terli group (109.8±2.0%, p<0.001 vs
shock+LRS; ﬁgure 4).
At T60, protein expression of V2 was higher in the shock-
only group than in the sham, shock+LRS, and shock+Terli
groups (144.3±8.1% vs 103±2.4%, 103.3±2.7%, and 117.0
±12.1%, p<0.05 for all; ﬁgure 4). At T120, the relationship
between the shock-only group and the other groups remained
the same, V2 protein expression continuing to be higher in the
shock-only group than in the sham, shock+LRS, and shock
+Terli groups (121.7±4.4% vs 98.3±4.4%, 89.6±5.5%, and
96.6±1.9%, p<0.01 for all; ﬁgure 4).
DISCUSSION
The most important ﬁnding of the present study was that terli-
pressin administration appears to be protective of renal function
in HS. That is in keeping with previous reports showing that
terlipressin is protective of other organs during HS.22 23 One of
the main consequences of severe traumatic injury is multiorgan
failure, and AKI (of any cause) can lead to acute renal failure.
Among trauma cases, the incidence of multiorgan failure can be
as high as 17%.24 There are few if any effective therapeutic
measures that can prevent or mitigate the deleterious conse-
quences of traumatic injury. Until recently, the strategy thought
to be optimal for the treatment of HS was volume crystalloid
resuscitation, typically performed during prehospital care.
However, that strategy can lead to volume overload, which has
been recognized as an independent predictor of mortality in
intensive care unit patients.25–27 In the previously mentioned
parallel study of HS in swine,22 we found that resuscitation with
LRS—albeit effective in decreasing mortality, recovering MAP,
decreasing serum levels of lactate, and increasing the cardiac
index—resulted in a signiﬁcant increase in intracranial pressure
and a signiﬁcant decrease in cerebral perfusion pressure, as well
as a signiﬁcant increase in the expression of AQP4, which might
indicate an increase in brain water content. In addition, resusci-
tation with LRS can worsen HS-induced pulmonary
Figure 1 Creatinine clearance and urine volume in the sham,
shock-only, shock+LRS, and shock+Terli groups at baseline, Shock, T30,
T60, and T120. ap<0.05 vs sham; bp<0.01 vs sham; cp<0.001 vs sham;
dp<0.05 vs shock-only; ep<0.01 vs shock-only; fp<0.001 vs shock-only;
gp<0.05 vs shock+LRS; hp<0.01 vs shock+LRS; ip<0.001 vs shock+LRS.
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Table 2 Biochemical variables in the various groups at the various time points evaluated in the various groups at the various time points
evaluated
Serum Period
Group Baseline Shock30 T30 T60 T120
Na (mEq/L)
Sham 145±3.1 149±5.9 144±4.7 154±9.2 135±10.50
Shock-only 138±1.2 141±5.3 140±5.7 132±4.3b 154±0.00
Shock+LRS 136±2.1 132±1.8a 131±2.2 131±1.2c 130±4.70
Shock+Terli 138±2.4 134±2.9a 138±2.7 134±1.5c 127±2.90
K (mEq/L)
Sham 4.6±0.3 4.7±0.2 4.6±0.2 5.1±0.3 4.8±0.10
Shock-only 4.8±0.2 5.9±0.4a 6.4±0.5b 6.0±0.9 7.7±0.00
Shock+LRS 4.2±0.1 6.4±0.4a 4.5±0.2f 5.1±0.1 5.9±0.30
Shock+Terli 4.3±0.1 5.3±0.2g 5.4±0.2d 5.4±0.2 5.6±0.40
Cl (mEq/L)
Sham 108±2.1 111±4.6 109±4.4 115±7.7 104±15.5
Shock-only 105±2.4 107±4.3 106±4.7 107±5.2 117±0.0
Shock+LRS 100±1.6 100±1.7 94±4.7 99±1.0a 94±4.60
Shock+Terli 104±2.2 99±2.2 102±2.1 96±3.1b 91±3.20
Mg (mg/dL)
Sham 1.9±0.14 1.7±0.10 1.7±0.10 1.7±0.14 1.8±0.10
Shock-only 1.8±0.08 2.1±0.08 2.2±0.11a 2.1±0.17 2.8±0.00
Shock+LRS 1.8±0.10 2.3±0.13 1.5±0.08f 1.5±0.09d 1.7±0.12
Shock+Terli 1.9±0.07 2.1±0.12 1.9±0.09h 2.1±0.10h 2.0±0.22
P (mg/dL)
Sham 9.3±1.00 9.4±0.91 9.7±0.74 9.9±0.91 10±2.00
Shock-only 8.8±0.52 10.6±0.59 12.2±0.91a 10.7±1.00 13±0.00
Shock+LRS 9.3±0.48 12.2±0.85 8.1±0.42f 8.3±0.51 9.7±0.90
Shock+Terli 8.5±0.40 10.1±0.56 10.8±0.47d 12.0±0.55h 11.6±1.8
Urea (mg/dL)
Sham 20.2±2.33 21.8±2.31 23.1±2.93 23.5±2.56 17.0±2.00
Shock-only 20.4±2.33 25.4±2.45 27.4±2.25 24.0±0.45 31.0±0.00
Shock+LRS 19.1±2.01 25.0±2.43 21.3±2.01 33.6±11.46 26.0±4.00
Shock+Terli 26.5±2.76 33.0±3.10 35.1±3.22a,h 37.2±3.20 41.1±5.10
Urine Period
Group Baseline Shock30 T30 T60 T120
UNaV (mEq/period)
Sham 0.5±0.1 1.2±0.7 0.6±0.3 0.6±0.2 0.8±0.3
Shock-only 0.7±0.1 0.6±0.3 0.2±0.1 0.2±0.1 0
Shock+LRS 0.4±0.1 0.4±0.2 20.5±4.7c,e 2.2±0.8 0.1±0.0
Shock+Terli 0.5±0.1 0.2±0.1 0.2±0.0i 0.5±0.3 0.3±0.1
UKV (mEq/period)
Sham 1.8±0.5 4.5±1.4 2.7±0.8 2.7±0.5 2.6±1.7
Shock-only 3.7±1.1 1.5±0.4a 0.2±0.1 0.1±0.0a 0
Shock+LRS 1.9±0.3 1.8±0.3a 12.7±5.7c,f 2.3±0.6d 0.6±0.2
Shock+Terli 2.2±0.3 1.8±0.8a 0.8±0.2h 0.9±0.3 1.5±0.7
UClV (mEq/period)
Sham 2.2±1.2 4.3±1.7 1.9±0.5 1.7±0.3 1.5±0.8
Shock-only 3.9±0.9 1.6±0.4 0.3±0.2 0.2±0.1 0
Shock+LRS 1.5±0.3 1.4±0.4 19.5±4.9b,e 3.7±1.3 0.4±0.2
Shock+Terli 2.7±0.6 1.3±0.6 0.6±0.2i 0.6±0.2 1.1±0.5
UMgV (mg/period)
Sham 3.2±1.3 1.8±0.4 1.5±0.9 1.2±0.4 0.7±0.5
Shock-only 6.3±1.5 1.2±0.2 0.1±0.4 0.3±0.1 0
Shock+LRS 3.7±0.7 2.2±0.6 9.1±1.6b,f 2.2±0.7 0.4±0.2
Shock+Terli 5.2±0.9 1.6±0.5 2.6±1.0i 2.0±0.6 3.3±0.8
UPV (mg/period)
Sham 1.7±1.4 11.3±6.3 7.4±3.8 7.9±3.3 3.2±1.6
Continued
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Table 2 Continued
Urine Period
Group Baseline Shock30 T30 T60 T120
Shock-only 4.3±2.3 4.7±2.1 1.2±0.8 0.2±0.2 0
Shock+LRS 1.9±1.2 7.8±2.5 74.1±20.8b,d 14±4.6d 3.8±3.0
Shock+Terli 3.3±1.6 2.4±1.4 6.1±3.04h 7.4±3.3 14.2±12.2
UureaV (mg/period)
Sham 184.4±49.3 371.8±88.1 223.8±66.6 210.4±43.4 162.9±113.1
Shock-only 489.5±82.9 117±22.9a 18.3±7.9 15.5±2.2a 0
Shock+LRS 203.7±31.1 140.9±280.6a 468.5±98.8a,e 193.4±48.6d 64.6±28.2
Shock+Terli 428.3±94.3 194.9±77.8 103.3±24.4i 87.6±27.9 282.6±103.6
Uosm (mOsm/kg)
Sham 735.8±96.1 748.7±102.3 739±85.7 734.6±90.6 617.5±59.5
Shock-only 563.4±95.7 592.6±65.5 446.5±154.5a 541.3±92.2 793±0.0
Shock+LRS 621.0±39.6 629.3±37.3 368.6±15.5c 464.7±27.8b 462.8±25.5
Shock+Terli 659.0±46.8 693.5±45.9 593.4±54.4b 522±39.5a 653±91.2
Values are mean±SE.
ap<0.05 vs sham; bp<0.01 vs sham; cp<0.001 vs sham; dp<0.05 vs shock-only; ep<0.01 vs shock-only; fp<0.001 vs shock-only; gp<0.05 vs shock+LRS; hp<0.01 vs shock+LR; ip<0.001
vs shock+LRS.
Sham, anesthetized but not subjected to hemorrhagic shock; Shock+LRS, subjected to hemorrhagic shock and subsequently treated with LRS at a volume equal to three times that of
the blood removed; Shock+Terli, subjected to hemorrhagic shock and subsequently treated with a 2 mg bolus of terlipressin; Shock30, 30 min after achieving the target MAP
(immediately prior to treatment); Shock-only, subjected to hemorrhagic shock and left untreated; T120, 120 min after treatment; T30, 30 min after treatment; T60, 60 min after
treatment; UClV, urinary excretion of chloride; UKV, urinary excretion of potassium; UMgV, urinary excretion of magnesium; UNaV, urinary excretion of sodium; Uosm, urine osmolality;
UureaV, urinary excretion of urea.
Figure 2 Expression of aquaporin 2 and NKCC2. Densitometry and immunoblotting in the sham, shock-only, shock+LRS and shock+Terli groups at
T60 and T120. ap<0.05 vs sham; bp<0.01 vs sham; cp<0.001 vs sham; dp<0.05 vs shock-only; ep<0.01 vs shock-only; fp<0.001 vs shock-only;
gp<0.05 vs shock+LRS; hp<0.01 vs shock+LRS; ip<0.001 vs shock+LRS.
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hyperpermeability, inﬂammation, acute lung injury, and acute
respiratory distress syndrome.28
Lee et al29 subjected mice to HS by amputating 80% of the
tail, a model that mimics what happens in a human victim of
bleeding. At 30 min after the onset of bleeding, the animals
received a mixture of plasma and LRS, after which they received
terlipressin, vasopressin, or high-volume resuscitation with LRS.
The authors found that, although terlipressin and vasopressin
restored MAP, terlipressin sustained a satisfactory MAP for a
longer period. Vasopressin and terlipressin were also found to
decrease serum lactate levels and pro-inﬂammatory cytokine
production, as well as to reduce lung injury and mortality.29
Even after ﬂuid resuscitation, HS-induced AKI is observed in
∼30% of patients admitted to intensive care units.30 In the
present study, we observed extremely high mortality in the
untreated animals, demonstrating the severity of a situation in
which there is high blood loss without timely administration of
appropriate treatment. We found that administration of terli-
pressin and high-volume resuscitation with LRS both decreased
mortality in this porcine model of HS.
As previously mentioned, creatinine clearance was highest in
the shock+LRS group at T30 and T60, whereas, at T120, it
was higher in the shock+Terli group than in the shock+LRS
group. That suggests that administration of terlipressin has long-
erlasting beneﬁcial effects than does high-volume resuscitation
with LRS.
In the present study, we found that HS induced hyponatremia
by T60, an effect that was probably attributable to vasopressin
release. Both treated groups also presented hyponatremia
throughout the study period, although it was more pronounced
Figure 3 Tubular injury in porcine kidney tissue. Representative photomicrographs of kidney tissue samples from the sham, shock-only, shock+LRS,
and shock+Terli groups at T60. Magniﬁcation, ×400. Bar graph of tubular injury scores. ap<0.001 vs sham; bp<0.01 vs shock-only.
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in the shock+Terli group at T120. In the shock+LRS group,
that could be attributed to hemodilution after volume expan-
sion, shock-induced vasopressin release, and increased urinary
excretion of sodium. In the shock+Terli group, the failure of
the treatment to reverse the HS-induced hyponatremia might be
attributable to the interaction between terlipressin and the vaso-
pressin receptors. Yim et al31 analyzed patients with variceal
bleeding treated with terlipressin and observed a signiﬁcant
reduction in serum sodium levels. However, after the discon-
tinuation of terlipressin, normal sodium levels were gradually
re-established.31 According to those authors, one possible
explanation for the hyponatremia is that terlipressin, in addition
to its vasoconstrictor effect via the V1a receptor, also acts on
the V2 receptor, increasing water reabsorption via AQP2 and
decreasing the serum levels of sodium. In the present study, the
shock-only group presented hyperkalemia, as was expected,
given that AKI decreases urinary excretion of potassium and
that HS is known to cause acidemia.32
Acute magnesium deﬁciency has been shown to increase pro-
duction of pro-inﬂammatory cytokines in rats.33 At some of the
time points evaluated, our shock+LRS pigs presented
hypochloremia and hypomagnesemia, both of which might have
been provoked by the volume expansion, which can increase
urinary excretion of chloride and magnesium. It of note that,
although the shock+LRS pigs showed higher urinary excretion
of sodium, potassium, chloride, magnesium, phosphorus, and
urea at T30, that was no longer the case at T120, when all of
those values were lower in the shock+LRS pigs than in the
sham and shock+Terli pigs.
As previously mentioned, we observed acute tubular necrosis
in the shock-only pigs at T60. We also found that administration
of terlipressin and high-volume resuscitation with LRS both pro-
tected renal tissue against HS-induced tubular necrosis. That
effect is likely attributable to the ability of both treatments
maintain renal perfusion pressure.
In the setting of HS, the pituitary gland releases vasopressin,
the V2 receptor of which increases the insertion of AQP2 into
the apical membrane of cells in the distal tubules and collector,
thereby increasing permeability to water.34 In addition, vaso-
pressin has been shown to increase the expression of NKCC2,
which is expressed in the thick ascending limb of Henle’s
loop.35 Furthermore, AKI is known to downregulate expression
Figure 4 Expression of the vasopressin receptors V1a and V2. Densitometry and immunoblotting in the sham, shock-only, shock+LRS, and shock
+Terli groups at T60 and T120. ap<0.05 vs sham; bp<0.01 vs sham; cp<0.001 vs sham; dp<0.05 vs shock-only; ep<0.01 vs shock-only; fp<0.001 vs
shock-only; gp<0.05 vs shock+LRS; hp<0.01 vs shock+LRS; ip<0.001 vs shock+LRS.
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of NKCC2 and AQP2.10 36 In a recent study, we demonstrated
that sepsis-induced AKI downregulates AQP2 and NKCC2
expression in the renal tissue of rats.9 In the present study, treat-
ment with terlipressin restored normal expression of NKCC2
and AQP2 after HS, although we did not observe any signiﬁcant
reversal of the HS-induced decrease in urine osmolality. These
data suggest that administration of terlipressin is more effective
than is high-volume resuscitation with LRS in protecting the
expression of sodium and water protein transporters in the
renal tubules.
As previously stated, V1a receptors are densely distributed in
vascular smooth muscle cells11 and V2 receptors are located
mainly in the kidney, stimulating water reabsorption.12 The
coordinated physiological response resulting from the inter-
action between those two types of receptors promotes vasocon-
striction and water retention, preserving circulating volume in
the setting of HS. Therefore, as expected, we found that our
shock-only pigs showed high expression of V1a and V2 at T60
and T120. An unexpected ﬁnding was that there was a decrease
in V1a expression in the shock+LRS pigs at T120. It has been
shown that even norepinephrine-induced vasoconstriction of the
afferent arteriole can be abolished by treatment with vasopressin
if the V1-type receptors are blocked.13 However, further studies
are needed in order to clarify these aspects.
In conclusion, we have demonstrated that administration of
terlipressin is equal to high-volume resuscitation with LRS in
treating the adverse renal effects of HS, although the risk of
ﬂuid overload and its consequences is greater when the latter
treatment is applied. Therefore, terlipressin might be useful for
preventing HS-induced AKI and could represent an alternative
to high-volume resuscitation in prehospital trauma care.
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